Penicillin Market Report
The report on the Global Penicillin Market is segmented By Drug Class (Natural Penicillin, Aminopenicillin, Beta-lactamase Inhibitors, Penicillinase-Resistant Penicillin, Anti-Pseudomonal Penicillin), Route of Administration (Oral, Intravenous, Intramuscular), Application (Urinary Tract Infections, Sexually Transmitted Diseases, Meningitis, Respiratory Tract Infections, Skin Infections, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region - COVID-19 Impact Analysis and Forecast to 2026.
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global Penicillin market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and forecast period is 2022-2026.
The report on the Global Penicillin Market is segmented By Drug Class (Natural Penicillin, Aminopenicillin, Beta-lactamase Inhibitors, Penicillinase-Resistant Penicillin, Anti-Pseudomonal Penicillin), Route of Administration (Oral, Intravenous, Intramuscular), Application (Urinary Tract Infections, Sexually Transmitted Diseases, Meningitis, Respiratory Tract Infections, Skin Infections, Others), Distribution Channel (...
Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
The Global Penicillin Market is expected to grow from USD xx billion in 2020 to USD xx billion by 2026 at a CAGR of over x% during the forecast period.
Figure: Global Penicillin Market Size, 2020-2026 (USD Billion)
Wish to know more about the study? Click here to get a free sample.
Penicillin is an antibiotic derived from the fungal mold Penicillium notatum. It is used to treat infection from various bacteria’s including streptococcus pneumonia, Neisseria gonorrhoea, clostridium, listeria, peptococcus, and peptostreptococcus.
Key players operating in the global Penicillin Market are-
The growth of the global penicillin market is primarily driven by an increasing number of people suffering from infectious diseases such as pneumonia, syphilis, and gonorrhoea.
Based on distribution channels, the penicillin market has been categorized into hospital pharmacies, retail pharmacies, and online pharmacies.
Geographically, the market in North America accounted for the largest market share in 2020 owing to the increasing prevalence of urinary tract infections and sexually transmitted diseases among consumers. Additionally, increased spending on R&D activities to develop advanced solutions is likely to propel market growth at a significant rate in the region.
The outbreak of coronavirus led to enforcement of lockdown and social distancing norms to curb the spread of the virus. This resulted in limited medical procedures at hospitals, which in turn affected the growth of the antibiotics market negatively for a short period. Also, the consumption of antibiotics in covid-19 patients was less.
Wish to get a customised report on this study? Register here.
The following is a list of the customers that the Penicillin market aims to convert the most:
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].
Pfizer, Inc (The U.S), Sanofi S.A. (France), Toyama Chemical Co., Ltd. (Japan), Novartis International AG (Switzerland), GlaxoSmithKline plc (UK), Merck & Co., Inc. (The U.S), Astellas Pharma Inc. (Japan), Johnson & Johnson (The U.S), Bayer AG (Germany), Abbott Laboratories (The U.S) and F. Hoffmann-La Roche AG (Switzerland) are among the key players in the penicillin market.
North America accounted for the largest share of penicillin market in 2020.
The hospital pharmacies segment accounted for the largest share of penicillin market in 2020.
Increasing number of people suffering from infectious diseases such as pneumonia, syphilis, and gonorrhoea, growing emphasis on organizing awareness campaigns by both private companies and government to control bacterial infectious diseases are the factors driving the growth of penicillin market.
Penicillin manufacturers, Penicillin suppliers, Penicillin distributors, Organizations, Government bodies are the target audience in the penicillin market.